Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome
Main findingResult — go to the resultAdjusted odds ratio 6.66 95% CI 2.21–20.07Authors' conclusion
Mid-pregnancy chemerin levels independently predict persistent hypertension after delivery in patients with PCOS and prior PHD.
Study context
- Population
- Women with and without polycystic ovary syndrome (PCOS) and previous pregnancy-related hypertensive disorders (PHD), studied 12 months after delivery; serum chemerin measured at 20 weeks of gestation
- Participants
- 92 women
- Exposure
- Persistent hypertension vs normotensive at 12 months postpartum
- Outcome
- Persistent hypertension one year after delivery, predicted by mid-pregnancy serum chemerin
- Follow-up
- 12 months after delivery
Main finding
As reported in the abstract
Adjusted odds ratio
6.66
95% CI 2.21–20.07
P = 0.0007
By group
Chemerin per 10 ng/mL
aOR 6.66 (95% CI 2.21–20.07); P = 0.0007
Per 10 ng/mL, as printed
Observational data: associations, not effects.
Further findings
Predictive performance of chemerin threshold (∼32.3 ng/mL) in women with PCOS
- PPV
- 57.1%
- NPV
- 82.9%
Original publication
Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome. Eur J Endocrinol. Published 16 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →